(Q44135091)
Statements
1 reference
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial (English)
1 reference
Jose Baselga
1 reference
Roy S Herbst
1 reference
Waun Ki Hong
1 reference
Anne-Marie Maddox
1 reference
Mace L Rothenberg
1 reference
Eric J Small
1 reference
Eric H Rubin
1 reference
Federico Rojo
1 reference
Helen Swaisland
1 reference
Steven D Averbuch
1 reference
Judith Ochs
1 reference
Patricia Mucci LoRusso
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference